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Abstract 
 
Objective(s) 
Mesenchymal stem cells (MSCs) are nonhematopoietic stromal cells that are capable of differentiating into 
and contribute to the regeneration of mesenchymal tissues. Human mesenchymal stem cells (hMSCs) are 
ideal targets in cell transplantation and tissue engineering. Enhanced green fluorescent protein (EGFP) has 
been an important reporter gene for gene therapy. The aim of this study was establishment of MSCs 
expressing GFP.  
Materials and Methods 
MSCs were isolated and characterized by Immunophenotyping. The pEGFP-N1 plasmid was extracted from 
previously transformed Escherichia. coli cells and transfected into MSCs using FuGENE HD transfection 
reagent. Stable cells were established in the presence of geneticin. Expression of GFP was detected by RT-
PCR, western blot analysis and immunoflorecent microscope.  
Results 
MSCs were successfully isolated and characterized. The MSCs transfected with the pEGFP-N1 plasmid 
expressed GFP both in mRNA and protein levels while cells transfected with empty vector did not.  
Conclusion 
The results suggested that this engineered cell line will be used in the future studies and can easily be traced 
in vivo.  
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Introduction 
It has been shown that the stem cells derived 
from bone marrow hold the ability of self 
renewal and differentiation into hematopoietic 
and mesenchymal cell lineages (1). The fact that 
this unique capability is extended to the non-
hematopoietic lineages including oval cells, 
hepatocytes, cholangiocytes (2, 3), neurons (4), 
skeletal muscle cells (5), and epithelial cells (6) 
is a relatively new observation (7). Nowadays 
human mesenchymal stem cells (hMSCs) have 
been studied for experimental and clinical 
purposes since the applications of human adult 
stem cells, such as hMSCs for cell therapy are of 
great clinical significance. One of the most 
popular reporter systems in fixed liver tissue is 
based on GFP, a 27-KDa monomeric protein 
isolated from jellyfish (8). This protein absorbs 
blue light and emits green fluorescence without 
exogenous substrates or cofactors and provides a 
convenient and efficient way to identify labeled 
cells.  In in vitro studies, the hMSCs have been a 
potential cellular source for clinical applications 
in regenerative medicine (9). Enhanced green 
fluorescent protein (EGFP) has been widely used 
as a new reporter, especially for marking stem 
cells (10-12). In spite of a few studies dealing 
with expression of GFP by viral vectors, there is 
no report on stable expression of GFP by   using 
PEGFP-N1 plasmid as non-viral expression 
systems in hMSCs (13-15). In this study, we 
established a mesanchymal stem cell (MSC) 
stably expressing GFP. 
 
Materials and Methods 
Isolation and culture of hMSCs 
Heparinized human bone marrow was obtained 
by aspiration from the posterior iliac of 3 healthy 
volunteers with 10-20 years old, after informed 
consent was obtained. Bone mononuclear cells 
(MNCs) were prepared by density gradient 
centrifugation with ficoll (below 1.073 g/ml, GE 
Healthcare, Sweden) then, the cells were 
washed, counted, and distributed in a 6-well 
plate at 1×10
6 cells/ml in Dulbecco's modified 
Eagle's medium-low glucose (MSCs medium, 
PAA, USA) supplemented with 10% fetal 
bovine serum (FBS) (Gibco, USA). These cells 
were incubated with 5% CO2 at 37 °C, and the 
unattached cells were removed during the period 
of 24-48 hr. Then the adherent cells were 
cultured and the medium was replaced every 4 
days. After ten days, individual colonies were 
collected, isolated, cultured and expanded. At an 
80% confluence, the cells were detached with a 
solution of 0.25% trypsin-0.02% ethylenediamine 
tetraacetic acid (EDTA, Gibco, USA) in PBS and 
used for passages or transfection. 
 
Immunophenotyping of hMSCs 
Presence of the cell surface antigens CD105, 
CD166, CD45, CD90, CD34, CD73 and CD14 
((DAKO, Denmark) were detected by flow 
cytometry. To do this, single cell suspensions 
derived from individual MSC donors (third 
passage) were washed twice in PBS 
supplemented with 0.5% (v/v) bovine serum 
albumin (BSA). Cell suspensions were incubated 
with titrated concentrations of the corresponding 
fluorescent  conjugated  antibodies  for  30 min  at        
4 º ºC (10
6 cells/ml in PBS/0.5% BSA). Then the 
samples were analyzed in a Partec pas III Flow 
cytometer (Partec, Germany).  
 
Plasmid propagation and extraction 
pEGFP-N1 plasmid  was kindly provided by 
Yoshikazu Kuwahara (Department of pathology, 
IDAC, Tohoku University, Japan). Bacterial 
strain Escherichia coli DH5α (Cinagen, Tehran, 
Iran) was used for propagation and preparation 
of the recombinant plasmid. The recombinant 
plasmid was extracted with High Pure Plasmid 
Extraction Kit™ according to the manufacturer’s 
instruction (Roche, Germany). The schematic 
representation of the recombinant plasmid is 
depicted in Figure 1.   
 
 
Figure 1. pEGFP vector. This is a shuttle vector that 
makes it possible to clone in a prokaryotic system and 
express in a eukaryotic system.  
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Establishment of GFP-expressing cells 
Third passage of the hMSC cells were 
transfected with the pEGFP-N1 vector using 
FuGENE HD transfection reagent according to 
manufacturer’s (Roche, Germany) protocol. One 
day before transfection, 7×10
5  cells/well were 
cultured  in  a  six-well  plate.  For  transfection,       
2 µg plasmid DNA was diluted in 100 µl of 
transfection reagent (mixed with 6 µl of 
FuGENE HD) in a sterile tube and incubated at 
room temperature for 15 min. Following the 
incubation, the transfection complex was added 
to the cells. After 48 hr, the medium was 
replaced with a selection medium containing an 
antibiotic. In fact, the MSCs capable of stably 
expressing GFP were selected in a medium 
containing 350 µg/ml geneticin (Roche, 
Germany) for at least 14 days, and this led to 
isolation of several stable clones (Stable 
expression of GFP approves the integration of its 
gene into the hMSCs genome). 
 
Reverse transcriptase (RT)-PCR 
Total RNA was extracted from the hMSC-GFP 
by using Trizol (Invitrogen, USA), and 500 ng 
of this RNA was reverse transcribed by using 
random hexamers and the superscript pre-
amplification system for first strand cDNA 
synthesis as instructed by the manufacturer 
(Invitrogen, USA).  
PCR was performed by Taq DNA polymerase 
(Roche, Germany) and the PCR condition 
included  an  initial  denaturation  at  94  °C  for        
5 min, followed by 30 cycles of 30 sec at 94 °C, 
30 sec at 59 °C and a final extension of 1 min at 
72 °C. β-actin expression was evaluated for 
normalization.  
Primer  set  for  GFP  consisted  of  a  forward         
(5′-GACGACGGCAACTACAAGA-3′) and a 
reverse (5′-GATGCCGTTCTTCTGCTT-3′) 
primer, which amplify 717 base pairs (bp) of 
GFP. For normalization, expression of b-actin 
was examined by using a primer pair including a 
forward (5′-TTC TAC AAT GAG CTG CGT 
GTG G-3′) and a reverse (5′-GTG TTG AAG 
GTC TCA AAC ATG AT-3′) primer. 
 
 
Western blot analysis 
Total proteins were extracted by using lysis M 
buffer (Roche, Germany) according to 
manufacturer’s instruction. The proteins were 
separated on a 12% SDS-PAGE and trans 
blotted onto PVDF membranes in a buffer 
containing 25 mM Tris HCl pH 8.3, 192 mM 
glycine and 20% methanol. Then, the PVDF 
membranes were incubated in 10 mM PBST 
(0.1% Tween 20 in PBS 10 mM) containing 3% 
skimmed milk for 12 hr. Afterwards the 
membranes were incubated with anti-GFP 
polyclonal antibodies (rabbit IgG, 1:10,000 
dilution in PBST) for 1 hr at room temperature 
followed by 5 times washing with PBST. Then 
the membranes were incubated with HRP 
conjugated-anti-rabbit  secondary antibodies 
(1:10,000 dilutions in PBST) at room 
temperature for 1 hr with gentle rocking. Finally, 
the membranes were washed 5 times with PBST 
and the immunoreactive bands were developed 
by ECL kit (Amersham, USA). 
 
Immunofluorescence microscopy                         
MSCs which were supposed to be capable of 
stable expression of GFP were further evaluated 
for two months after transfection by fluorescence 
microscopy on a Nikon Eclipse TE300 inverted 
microscope (Nikon instruments; Melville, NY) 
with filter sets designed for EGFP. Digital 
images were taken using a nikon E8400 color 
camera (Nikon, Japan). After transfection, MSCs 
were trypsinized and the transfection efficiency 
was determined by counting GFP expressing 
cells versus non-expressing cells under the 
fluorescent microscope. 
 
MTT assay 
Cell viability following transfection was 
determined by MTT assay. To do this, 1×10
4 
transfected cells/well were seeded in a 96-well 
plate and on seventh day the cells were 
incubated with 10 µl of 3-(4,5-dimethlthiazol-2-
yl)-2,5 diphenyltetrazolium bromide (MTT, 
Sigma) with a concentration of 5 mg/ml at 37 °C 
in 5% CO2 atmosphere for 4 hr. Then the 
reaction was stopped by addition of 10% SDS in 
0.01 M HCl, and cell viability was measured 
using a microplate reader.                                                        
 
Results 
Isolation and culture of hMSCs  
MNCs were isolated from human (10-20 years 
old)    bone marrow by density gradient 
fractionation and adherence to plastic flasks.  
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After 10 days, individual colonies were 
selected, cultured and expanded in tissue 
dishes. Following reaching 80% confluence, 
cells were detached by trypsinization and 
passaged every 4-5 days for 12 passages and 
showed no morphologic changes. Fibroblast-
like morphological features could be seen in 
typical primary or passaged hMSCs (Figure 2). 
 
Immunophnotyping of hMSCs 
Human bone marrow-derived MSCs were 
analyzed routinely for the presence of typical 
MSC-related cell surface antigens by flow 
cytometric analysis. These cells showed the 
typical antigenic profile of MSC and were 
positive for CD166, CD105, CD90 and CD73 
antigens. They were also negative for the 
antigens CD45, CD34 and CD14 (Figure 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. MSCs which are approximately 90% 
confluent. Isolated mesanchymal Stem Cells present 
fibroblast like cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Cell surface antigen profile of adult human 
bone marrow-derived MSC. Flow cytometric analysis 
demonstrates that propagated MSC (passage 3) are 
positive for the antigens CD166, CD105, CD90 and 
CD73 but negative for CD45, CD34 and CD14. 
Expression of GFP in MSCs 
Stable engineered MSCs were generated in the 
presence of geneticin. RT-PCR was performed 
to investigate the expression of GFP by the 
transfected cells. GFP mRNA was expressed 
by the isolated stable clones, but there was no 
expression in the MSCs transfected with 
empty vector (Figure 4). 
Transfection efficiency was about 60 percent 
as determined by observation of the cells under 
the fluorescent microscope. Next, western blot 
analysis was performed for  detection of GFP 
protein. Cells transfected with the recombinant 
vector expressed GFP protein, whereas the cells 
transfected with empty vector do not (Figure 5).  
 
 
 
 
 
 
 
Figure 4. (A) Expression of GFP by stable clones of 
MSCs. RNA was extracted from cells transfected with the 
recombinant vector and also cells transfected with empty 
vector. cDNA was synthesized and RT-PCR was 
performed using a pair of primers specific for GFP. MSCs 
transfected with the recombinant plasmid expressed GFP 
mRNA and revealed a 717-bp fragment of GFP mRNA 
following PCR (Lane 1), whereas MSCs transfected with 
empty vector revealed no expression (Lane 2). Lower 
figure indicates the expression of b-actin in both stable 
clones of MSC, i.e., transfected with the recombinant or 
the empty vector. M; 100-bp ladder marker.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Western blot analysis of GFP expression by 
the stables clones. MSCs transfected with the 
recombinant vector expressed GFP protein (Lane 2), 
whereas in MSCs transfected with the empty vector 
expression was not observed (Lane 1). 
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Figure 6. Fluorescence microscopy showed GFP 
expression in transfected mesenchymal stem cells. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Cell viability of stable MSCs following 
transfection with pEGFP vector was determined by 
MTT assay on day 7 post transfection. There was no 
difference between the viability of the cells transfected 
with the empty vector (MSC-V) or the recombinant 
vector (MSC-GFP) (Mean ± SD: P> 0.05). 
 
Finally the expression of GFP by the stable 
clones of MSCs was confirmed by florescence 
microscopy (Figure 6). Eventually, no toxicity 
effect by GFP was observed as determined via 
MTT assay (Figure 7).      
 
Discussion 
In this study, MSCs were isolated and 
transfected with a recombinant plasmid 
containing GFP gene. BrdU, fluorescent dye, 
green fluorescent protein, magnetic, and 
isotope labeling techniques are some of the 
most widely used techniques for stem cell 
labeling in stem cell transplants fields. The 
selection of each of these tracing techniques 
depends on the aims of the experiment and 
also the stem cells characteristics. The BrdU 
and fluorescent dye techniques lie among the 
firstly used tracing methods because of their 
convenience. But the problem with these 
techniques is the gradual decreasing in their 
labeling intensity as the time passes, and also 
their inability for in vivo tracing of labeled 
stem cells (16-21). Although MRI and isotope 
labeling techniques are used for in vivo tracing 
of stem cells because of their non-invasive 
properties, the former technique can result in 
false positives and the latter is limited by the 
specific stem cell markers (22-25). 
GFP is widely applied for stem cell tracing 
because of the possibility of its stable 
expression,  high  specificity,  and  its  easy        
in vivo tracing, however, its application is 
limited by certain cytoxicity of high GFP 
levels (10, 26). Lee et al transduced hMSCs by 
a GFP-retroviral vector (13). Viral vectors 
have been also used in other similar studies 
(14-15). But in the present study the non-viral 
pEGFP-N1 vector was used for transfection of 
hMSCs and stable expression of GFP in these 
cells.  It should be noted that the safety of viral 
vectors is a major concern in application of 
MSCs in transplantation. Therefore, the fact 
that the vector used in the present study is a 
plasmid-based vector but not a viral derived 
vector would be considered as an advantage 
over the other studies. Recently, improvement 
of a bacterial fluorescence has been reported 
by Yoo et al. In their study the fluorescence of 
bacterial cells expressing a variant of GFP 
(GFPm) was reduced to background levels by 
entire replacement of the leucine residues of 
GFPm by 5, 5, 5- trifluoroleucine. The median 
fluorescence of cells expressing this 
fluorinated protein was improved about 650-
fold when compared to that of expressing non-
fluorinated GFPm (26). The possibility of 
repairing the liver injuries in wild-type mice 
by transplantation of both wild type and green-
GFP bone marrow has been reported by 
Beaudry  et al. and they detected the GFP 
expression in the transplanted cells (27).  The 
therapeutic effects of tyrosine hydroxylase 
(TH) transfected NdSCs-D-BMSCs on 
Parkinson's disease through different 
transplantation protocols were investigated, 
which resulted in GFP expression by 62.1% of 
the transfected cells 5 day post transfection  
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and the rate of co-expression with TH was 
83.5% (28). Also, GFP or GFPm has been 
widely used in cardiomyocytes regeneration 
(29, 30), retinal pigment epithelium cell repair 
(31), and skin repair (32). In the present study, 
FuGENE HD transfection reagent was used for 
transfection of the pEGFP-N1 into the MSCs. 
Simple methodology, minimal optimization, 
low cytotoxicity and ability to provide high 
transfection efficiency even in the presence of 
serum are advantages of FuGENE HD 
transfection reagent. Taking together, in this 
study we reported the stable expression of 
GFP in bone marrow derived mesanchymal 
stem cells and our results suggested that this 
technique would be applicable for labeling the 
MSCs in their potential future applications. 
Despite the advantages of GFP labeling of 
stem cells and transgenic mice, there is some 
limitations including (i) it is difficult to 
prepare a continuous, high performance and 
stably GFP expressing clone; (ii) high levels of 
GFP expression could affect cell growth by 
decreasing the growth rate which suggests that 
GFP may be cytotoxic; (iii) it is impossible to 
amplify GFP signals, therefore when its 
expression by stem cells is low it could not be 
detected and can’t be used for quantitative 
analysis.  
 
Conclusion 
In this study the MSCs were successfully 
isolated and a cell line stably expressing GFP 
was established. In future studies, this cell line 
will be used and can easily be traced in vivo.  
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